Further in vitro and in vivo results indicated that long‐term minocycline treatment downregulated microglial glycolysis levels through the EMB/MCT4 axis, promoting the transformation of microglia to an anti‐inflammatory phenotype by inhibiting the activation of the STING pathway, thereby improving post‐stroke neuroinflammation. The gene discussed is SLC16A3; the disease is Stroke.